Acromelalgia (Erythromelalgia)

Acromelalgia (Erythromelalgia) – Treatment Options

Introduction
Acromelalgia, also called erythromelalgia, is a rare neurovascular pain disorder characterized by recurrent episodes of burning pain, erythema, and warmth of the extremities, often triggered by heat or exercise and relieved by cooling. It can be primary (idiopathic or hereditary, often associated with sodium channel mutations such as SCN9A) or secondary (linked to myeloproliferative disorders, autoimmune diseases, neuropathies, or medications). Treatment is challenging and focuses on symptomatic relief, addressing underlying causes, and improving quality of life.

1. General Measures and Supportive Care

• Avoidance of triggers such as heat exposure, tight footwear, and prolonged standing.

• Cooling strategies (fans, cool water immersion) to alleviate acute symptoms, though prolonged immersion should be avoided to prevent skin damage.

• Proper skin care to prevent secondary infections due to chronic cooling or scratching.

2. Pharmacologic Therapies

• Aspirin:

  • Especially effective in secondary erythromelalgia associated with myeloproliferative disorders (e.g., polycythemia vera, essential thrombocythemia).

  • Typical dose: 81–325 mg daily, adjusted based on clinical response and bleeding risk.

• Neuropathic pain agents:

  • Gabapentin or pregabalin: Reduce neuropathic pain and burning sensations.

  • Tricyclic antidepressants (amitriptyline, nortriptyline): Used for pain modulation.

  • SNRIs (duloxetine, venlafaxine): May be effective in neuropathic components.

• Sodium channel blockers:

  • Mexiletine (oral sodium channel blocker): Effective in some hereditary cases with SCN9A mutations.

  • Lidocaine (IV infusions or topical patches): May provide temporary relief.

• Other systemic options:

  • Prostaglandin inhibitors (indomethacin, misoprostol) in select patients.

  • SSRIs (sertraline, fluoxetine): Reported benefit in some cases.

  • Carbamazepine or oxcarbazepine: May reduce neuronal hyperexcitability.

3. Topical and Local Therapies

• Capsaicin cream: Can reduce pain sensitivity after repeated application, though initial burning may limit use.

• Topical lidocaine: For localized pain relief.

• Compounded topical agents (e.g., amitriptyline/ketamine) in refractory pain cases.

4. Interventional and Advanced Therapies

• Sympathetic nerve blocks: May provide temporary improvement in refractory cases.

• Spinal cord stimulation or dorsal root ganglion stimulation: Considered in severe, treatment-resistant erythromelalgia.

• Botulinum toxin injections: Limited evidence, but some patients report pain relief.

5. Management of Secondary Causes

• Myeloproliferative disorders: Cytoreductive therapy (hydroxyurea, interferon) plus aspirin.

• Autoimmune disease–related erythromelalgia: Immunosuppressants or corticosteroids.

• Medication-induced cases: Discontinuation of offending drugs (e.g., calcium channel blockers, bromocriptine).

6. Monitoring and Long-Term Care

• Regular assessment of pain severity, quality of life, and functional impact.

• Monitoring for complications from chronic cooling (skin ulceration, infection).

• Psychological support and pain management counseling for chronic disease burden.

7. Multidisciplinary Approach

• Hematology input for myeloproliferative causes.

• Neurology for neuropathic pain management.

• Pain specialists for refractory cases requiring advanced pain control.

• Dermatology for skin care and wound prevention.